Home›Search›CNS Drugs

CNS Drugs

ADIS INT LTD · Switzerland · Est. 1952

ISSN1179-1934

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q1+25

Total60

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

1.884

H-Index

162

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

2.233

Total Works

2,925

Total Citations

136,582

2yr Mean Citedness

5.90

Free JIF alternative

Aims & Scope

CNS Drugs provides researchers and healthcare professionals with essential information on the most important aspects of drug therapies used for the management of neurological and psychiatric disorders. Via a program of reviews and original research articles, the journal addresses major issues relating to drug therapy of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of neurological and psychiatric disorders; and the practical management of specific clinical situations.

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 25% in field

General Information

Country / RegionSwitzerland

Primary LanguageEnglish

1st Year Published1952

FrequencyMonthly

StatusActive (last: 2026)

Total Publications2,925

Publisher OrgAdis, Springer Healthcare

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

📦 Long-term Preservation

CLOCKSSPortico

Think.Check.Submit Compliance

thinkchecksubmit.org

7/12 · 58%

✅

Do you know the journal / publisher?

ADIS INT LTD

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1179-1934

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

CLOCKSS, Portico

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Neurology (clinical)Q1

Pharmacology (medical)Q1

Psychiatry and Mental HealthQ1

Subject Classification

Web of Science Categories

Clinical NeurologyPharmacology & PharmacyPsychiatry

Scopus Categories

Pharmacology (medical)Neurology (clinical)Psychiatry and Mental Health

Research Topics (OpenAlex)

Schizophrenia research and treatmentEpilepsy research and treatmentTreatment of Major DepressionPharmacological Effects and Toxicity StudiesBipolar Disorder and TreatmentNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchParkinson's Disease Mechanisms and TreatmentsAttention Deficit Hyperactivity DisorderMultiple Sclerosis Research Studies